Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 926-135-3 | CAS number: -
Endpoint summary
Administrative data
Description of key information
Eye irritation in vitro: not irritant
Skin irritation in vitro: not irritant
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The potential of the test substance to cause ocular irritation was assessed by a single topical application of 50µL of undiluted Efka-K-111 Solvent free to a reconstructed three-dimensional human cornea model (EpiOcular™). Two EpiOcular™ tissues were incubated with the test substance for 30 minutes followed by a 2-hours post-incubation period. Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test (MTT). The mean viability of the test-substance treated tissues was 81.8%. Consequently, the test substance does not show an eye irritation potential in the in vitro eye irritation test strategy under the test conditions chosen. No further in vitro assays (BCOP) were required, since for non-irritant substances the differentiation between irritant and corrosive properties is unnecessary.
The potential of the test substance to cause dermal irritation was assessed by a single topical application of 30 μL of the undiluted test substance to a reconstructed three-dimensional human epidermis model (EpiDerm™). The irritation test was performed with three EpiDerm™ tissues, which were incubated with the test substance for 1 hour followed by a 42-hours post-incubation period. Tissue destruction was determined by measuring the metabolic activity of the tissue after exposure/post-incubation using a colorimetric test (MTT) to measure relative viability.
The mean viability of the test-substance treated tissues was 90.1%. Positive and negative control tissues gave results within the historical control ranges.
Based on the observed results, it was concluded, that Efka-K-111 Solvent free does not show a skin irritation potential in the EpiDerm™ in vitro skin irritation and corrosion test strategy under the test conditions
chosen. No further test for skin corrosion is required.
Justification for classification or non-classification
Efka-K-111 was not irritant to skin or eyes in in vitro assays. No classification is required according to CLP regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
